Trials / Completed
CompletedNCT04496869
Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment
Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment, a French Cohort
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 435 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- Female
- Age
- 18 Years – 43 Years
- Healthy volunteers
- Not accepted
Summary
In France, one couple in eight encounters difficulties to conceive. The diagnosis of infertility frequently leads to symptoms of anxiety and depression. These symptoms appear to be higher than in the general population. Some recent studies have looked at the relationship between anxiety and depression in ART cares. Results are controversial, but it appears that patients with lower levels of anxiety and depression have higher pregnancy rates. Moreover, in couple, women seem to have more symptoms of anxiety and depression than men. First epidemiological studies related to the COVID 19 pandemic have shown strong psychological impact on the general population with an anxiety rate estimated at more than 30%. With COVID 19 pandemic and cessation of ART, it is highly likely that psychic symptoms of anxiety or even depression may have appeared or worsened in women undergoing infertility treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Online questionnaire | the investigators sent by email a Googleform online questionnaires to women followed in ART center of HFME (Hospital Femme-Mère-Enfant) . Questions are about demographic characteristics, ART history, feeling during the lockdown. To evaluate psychological impact, the investigators use PSS10 and HADS scales. Both scales are worldwide validated and used in recent COVID19's research. the investigators add some quantitative questions about de feeling during the look down, ART interruption, pregnancy desire. |
Timeline
- Start date
- 2020-07-07
- Primary completion
- 2020-08-31
- Completion
- 2020-08-31
- First posted
- 2020-08-03
- Last updated
- 2021-07-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04496869. Inclusion in this directory is not an endorsement.